S&W SEED CO (SANW)

US7851351046 - Common Stock

9.22  +2.15 (+30.41%)

After market: 9.38 +0.16 (+1.74%)

Fundamental Rating

1

Taking everything into account, SANW scores 1 out of 10 in our fundamental rating. SANW was compared to 90 industry peers in the Food Products industry. SANW has a bad profitability rating. Also its financial health evaluation is rather negative. SANW has a expensive valuation and it also scores bad on growth.



0

1. Profitability

1.1 Basic Checks

SANW had negative earnings in the past year.
SANW had a negative operating cash flow in the past year.
SANW had negative earnings in 4 of the past 5 years.
In the past 5 years SANW always reported negative operating cash flow.

1.2 Ratios

Looking at the Return On Assets, with a value of -42.25%, SANW is doing worse than 85.56% of the companies in the same industry.
SANW has a Return On Equity of -112.20%. This is amonst the worse of the industry: SANW underperforms 83.33% of its industry peers.
Industry RankSector Rank
ROA -42.25%
ROE -112.2%
ROIC N/A
ROA(3y)-14.5%
ROA(5y)-13.76%
ROE(3y)-38.06%
ROE(5y)-32.83%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

SANW has a Gross Margin (23.19%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of SANW has declined.
The Profit Margin and Operating Margin are not available for SANW so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 23.19%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y17.05%
GM growth 5Y-6.75%

1

2. Health

2.1 Basic Checks

SANW does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for SANW has been reduced compared to 1 year ago.
Compared to 5 years ago, SANW has less shares outstanding
The debt/assets ratio for SANW is higher compared to a year ago.

2.2 Solvency

SANW has an Altman-Z score of -1.89. This is a bad value and indicates that SANW is not financially healthy and even has some risk of bankruptcy.
SANW's Altman-Z score of -1.89 is on the low side compared to the rest of the industry. SANW is outperformed by 81.11% of its industry peers.
SANW has a Debt/Equity ratio of 0.57. This is a neutral value indicating SANW is somewhat dependend on debt financing.
The Debt to Equity ratio of SANW (0.57) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF N/A
Altman-Z -1.89
ROIC/WACCN/A
WACC8.95%

2.3 Liquidity

A Current Ratio of 0.85 indicates that SANW may have some problems paying its short term obligations.
SANW has a Current ratio of 0.85. This is in the lower half of the industry: SANW underperforms 75.56% of its industry peers.
A Quick Ratio of 0.37 indicates that SANW may have some problems paying its short term obligations.
With a Quick ratio value of 0.37, SANW is not doing good in the industry: 82.22% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.85
Quick Ratio 0.37

1

3. Growth

3.1 Past

SANW shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -51.04%.
SANW shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -25.36%.
Measured over the past years, SANW shows a very negative growth in Revenue. The Revenue has been decreasing by -11.24% on average per year.
EPS 1Y (TTM)-51.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-5014.29%
Revenue 1Y (TTM)-25.36%
Revenue growth 3Y-10.39%
Revenue growth 5Y-11.24%
Sales Q2Q%-49.43%

3.2 Future

The Earnings Per Share is expected to grow by 40.89% on average over the next years. This is a very strong growth
Based on estimates for the next years, SANW will show a very negative growth in Revenue. The Revenue will decrease by -22.69% on average per year.
EPS Next Y97.77%
EPS Next 2Y40.89%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-45.63%
Revenue Next 2Y-22.69%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

1

4. Valuation

4.1 Price/Earnings Ratio

SANW reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SANW. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

SANW's earnings are expected to grow with 40.89% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.89%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

SANW does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

S&W SEED CO

NASDAQ:SANW (12/27/2024, 8:00:02 PM)

After market: 9.38 +0.16 (+1.74%)

9.22

+2.15 (+30.41%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)11-13 2024-11-13/bmo
Earnings (Next)02-12 2025-02-12/bmo
Inst Owners60.13%
Inst Owner Change-0.5%
Ins Owners2.78%
Ins Owner Change-0.24%
Market Cap21.02M
Analysts82.86
Price Target10.2 (10.63%)
Short Float %1.92%
Short Ratio0.51
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-19.34%
Min Revenue beat(2)-36.83%
Max Revenue beat(2)-1.85%
Revenue beat(4)0
Avg Revenue beat(4)-19.26%
Min Revenue beat(4)-36.83%
Max Revenue beat(4)-1.85%
Revenue beat(8)2
Avg Revenue beat(8)-9.3%
Revenue beat(12)3
Avg Revenue beat(12)-8.41%
Revenue beat(16)6
Avg Revenue beat(16)-4.99%
PT rev (1m)0%
PT rev (3m)400%
EPS NQ rev (1m)0%
EPS NQ rev (3m)10%
EPS NY rev (1m)0%
EPS NY rev (3m)-22.73%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-56.67%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-53.95%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.4
P/FCF N/A
P/OCF N/A
P/B 0.58
P/tB 1.57
EV/EBITDA N/A
EPS(TTM)-12.34
EYN/A
EPS(NY)-0.18
Fwd EYN/A
FCF(TTM)-3.74
FCFYN/A
OCF(TTM)-3.1
OCFYN/A
SpS22.95
BVpS15.95
TBVpS5.86
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -42.25%
ROE -112.2%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 23.19%
FCFM N/A
ROA(3y)-14.5%
ROA(5y)-13.76%
ROE(3y)-38.06%
ROE(5y)-32.83%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y17.05%
GM growth 5Y-6.75%
F-Score3
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 35.73%
Cap/Sales 2.75%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.85
Quick Ratio 0.37
Altman-Z -1.89
F-Score3
WACC8.95%
ROIC/WACCN/A
Cap/Depr(3y)30.82%
Cap/Depr(5y)40.74%
Cap/Sales(3y)2.22%
Cap/Sales(5y)2.75%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-51.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-5014.29%
EPS Next Y97.77%
EPS Next 2Y40.89%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-25.36%
Revenue growth 3Y-10.39%
Revenue growth 5Y-11.24%
Sales Q2Q%-49.43%
Revenue Next Year-45.63%
Revenue Next 2Y-22.69%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y10.74%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year46.84%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y61.26%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y64.98%
OCF growth 3YN/A
OCF growth 5YN/A